Recent legal changes, introduced by EA PO, allows to include national patents in the EA pharmaceutical registry (active from March 2021); however, not every member country is yet willing to submit actual information on its patents. Therefore, national registries of pharmaceutical patents are still necessary.
Russian registry is still in its prototype stage and it is expected that legal framework shall be finished soon. Yury Zubov, head of RU PTO, recently stressed a necessity of parallel registry, deriving from experience, already available in EAPO. The head of the latter, Grigory Ivliev, confirmed the EA legal base is ready and theoretically every claimant may add a national patent to EA registry. But not all national PTOs are willing to provide restricted information on the patents, so the registry is doomed to be incomplete till then.
The Eurasian Patent Office has recently received its first one thousand industrial design applications. Established…
Turkmenistan has officially joined the Protocol on the Protection of Industrial Designs to the Eurasian…
The Intellectual Property Court reviewed the cassation appeal of the foreign company "Gymworld Inc." (Republic…
A Russian entrepreneur has been fined $250000 for illegally printing copies of the Harry Potter…
On July 16, 2024, the cultural event celebrating the "30th Anniversary of the Eurasian Patent…
This year hundreds of delegates from WIPO’s 193 Member States have joined the July 9-17…